HUMA 10-Q: SEC filing
Humacyte, Inc.
Filed with the SEC on · accession 0001193125-26-455588
HUMA filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +29.6% by the first close after the filing.
Summary of the filing
Humacyte, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and disclosing various financing activities including registered direct offerings, an ATM facility, and a revenue interest purchase agreement.
Key details
How HUMA stock reacted
Close before
$0.46
Nov 9, 2026
First close after
+29.61%
$0.59
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for HUMA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for HUMA?
Click hereFrequently asked questions
What did HUMA file with the SEC on Nov 10, 2026?
HUMA filed a 10-Q (SEC filing). Humacyte, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and disclosing various financing activities including registered direct offerings, an ATM facility, and a revenue interest purchase agreement.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did HUMA stock react to this filing?
HUMA closed at $0.46 before the filing and $0.59 on Nov 10, 2026 (+29.61%).
Other HUMA SEC filings
Get alerts when HUMA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days